HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhiro Yonetoku Selected Research

AS 1907417

10/2010AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhiro Yonetoku Research Topics

Disease

3Type 2 Diabetes Mellitus (MODY)
02/2013 - 10/2010
1Hypoglycemia (Reactive Hypoglycemia)
11/2010
1Eosinophilia
11/2008
1Hepatitis
07/2006
1Overactive Urinary Bladder (Overactive Bladder)
10/2005

Drug/Important Bio-Agent (IBA)

2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
02/2013 - 10/2010
1Glyburide (Glibenclamide)FDA LinkGeneric
11/2010
12- (4- bromophenyl)- 6- methyl- N- (2- (1- oxidopyridin- 3- yl)ethyl)pyrimidin- 4- amineIBA
11/2010
1Insulin (Novolin)FDA Link
11/2010
1Glucose (Dextrose)FDA LinkGeneric
10/2010
1AS 1907417IBA
10/2010
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2010
1OvalbuminIBA
11/2008
1PhytohemagglutininsIBA
07/2006
1Interleukin-2 (IL2)IBA
07/2006
1Calcium Release Activated Calcium ChannelsIBA
07/2006
1Concanavalin AIBA
07/2006
1oxybutynin (Tavor)FDA LinkGeneric
10/2005